Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ANXA2 | P07355 | 1/20 | 0.48 |
| ▸ | S100A10 | P60903 | 1/20 | 0.48 |
| ▸ | PDE7A | Q13946 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL613358 | 0.90 | CYP3A4 (0.48) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL30398364 | 0.84 | MAOA (0.47) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL6366825 | 0.84 | MAOA (0.47) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL29053002 | 0.82 | MEN1 (0.49) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL19041461 | 0.82 | CYP3A4 (0.61) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL928688 | 0.82 | NR1H2 (0.61) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL11630774 | 0.82 | TDP1 (0.56) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL9485438 | 0.82 | CYP3A4 (1.00) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| 4,4'-Thiodianiline SCHEMBL49068 | 0.82 | CYP3A4 (1.00) | CYP3A4TSHRMAPK1MAPTMEN1 | |
| SCHEMBL9485453 | 0.82 | CYP3A4 (1.00) | CYP3A4TSHRMAPK1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035513-A1 | RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-02-05 | — | — | US | disclosed |
| EP-4578892-A1 | RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL | Asahi Kasei Kabushiki Kaisha (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-112368641-A | Photosensitive resin composition, photosensitive sheet, cured film of photosensitive resin composition and photosensitive sheet, method for producing cured film, and electronic component | 东丽株式会社 | 2021-02-12 | — | — | CN | disclosed |
| US-6307008-B1 | CYCLIC TETRAACIDS WITH AROMATIC DIAMINES AS ADHESIVES FOR SEMICONDUCTORS AND ADHESIVES | SAEHAN INDUSTRIES CORPORATION (KR) | 2001-10-23 | — | — | US | disclosed |
| US-5847071-A | Photosensitive resin composition | HITACHI, CHEMICAL CO., LTD. (JP) | 1998-12-08 | — | — | US | disclosed |
| US-5668248-A | POLYAMIC ACID ESTERS | HITACHI CHEMICAL CO., LTD. (JP) | 1997-09-16 | — | — | US | disclosed |
| EP-0705863-A1 | Two stage melt polymerization process for making polybenzimidazoles | HOECHST CELANESE CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
| US-5472823-A | Polyamic acids | HITACHI CHEMICAL CO., LTD. (JP) | 1995-12-05 | — | — | US | disclosed |
| US-4717764-A | Two stage melt polymerization process for making polymers containing aromatic amide groups | CELANESE CORPORATION (US) | 1988-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035513-A1 | RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL | TAF1, TAF1L, TAF9 | CYP3A4 4008/4885TSHR 1152/4885MAPK1 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.